Biocon sets price band for Syngene's IPO

16 Jul 2015 Evaluate

Biocon has set the price band for an initial public offering of its clinical research services arm, Syngene International, at Rs 240-250 a share. Syngene’s IPO shall open for subscription on July 27 and close on July 29.

Earlier in June, Syngene received the Foreign Investment Promotion Board (FIPB) approval for raising foreign investment in the company to 44 per cent from the earlier approved 10 per cent. The equity shares of Syngene are proposed to be listed on BSE and the National Stock Exchange (NSE).

Biocon is India’s largest and Asia’s leading biotechnology company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

395.25 -2.80 (-0.70%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×